Life Sciences is an international journal publishing articles that emphasize the molecular, cellular, and functional basis of therapy. The journal emphasizes the understanding of mechanism that is relevant to all aspects of human disease and translation to patients. All articles are rigorously reviewed.
The Journal favors publication of full-length papers where modern scientific technologies are used to explain molecular, cellular and physiological mechanisms. Articles that merely report observations are rarely accepted. Recommendations from the Declaration of Helsinki or NIH guidelines for care and use of laboratory animals must be adhered to. Articles should be written at a level accessible to readers who are non-specialists in the topic of the article themselves, but who are interested in the research. The Journal welcomes reviews on topics of wide interest to investigators in the life sciences. We particularly encourage submission of brief, focused reviews containing high-quality artwork and require the use of mechanistic summary diagrams.
中科院SCI分區(qū)
Life Sciences雜志中科院分區(qū)信息
2023年12月升級(jí)版
綜述:否
TOP期刊:是
大類:醫(yī)學(xué) 2區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實(shí)驗(yàn) 2區(qū)
PHARMACOLOGY & PHARMACY 藥學(xué) 2區(qū)
2022年12月升級(jí)版
綜述:否
TOP期刊:是
大類:醫(yī)學(xué) 2區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實(shí)驗(yàn) 2區(qū)
PHARMACOLOGY & PHARMACY 藥學(xué) 2區(qū)
2021年12月舊的升級(jí)版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實(shí)驗(yàn) 3區(qū)
PHARMACOLOGY & PHARMACY 藥學(xué) 3區(qū)
2021年12月基礎(chǔ)版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 2區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實(shí)驗(yàn) 3區(qū)
PHARMACOLOGY & PHARMACY 藥學(xué) 2區(qū)
2021年12月升級(jí)版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實(shí)驗(yàn) 3區(qū)
PHARMACOLOGY & PHARMACY 藥學(xué) 3區(qū)
2020年12月舊的升級(jí)版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué):研究與實(shí)驗(yàn) 3區(qū)
大類:Pharmacology, Toxicology and Pharmaceutics小類:General Pharmacology, Toxicology and Pharmaceutics
Q1
2 / 80
98%
大類:Pharmacology, Toxicology and Pharmaceutics小類:General Biochemistry, Genetics and Molecular Biology
Q1
25 / 221
88%
歷年影響因子和期刊自引率
投稿經(jīng)驗(yàn)
Life Sciences雜志投稿經(jīng)驗(yàn)
該雜志是一本國(guó)際頂級(jí)雜志,在醫(yī)學(xué)-MEDICINE, RESEARCH & EXPERIMENTAL學(xué)科領(lǐng)域中屬于核心刊物,是能夠綜合反映該學(xué)科領(lǐng)域當(dāng)前最高發(fā)展水平的學(xué)術(shù)期刊。在國(guó)際上有很高的學(xué)術(shù)影響力,行業(yè)關(guān)注度很高,已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄,該雜志在MEDICINE, RESEARCH & EXPERIMENTAL綜合專業(yè)領(lǐng)域?qū)I(yè)度認(rèn)可很高,對(duì)稿件內(nèi)容的創(chuàng)新性和學(xué)術(shù)性要求非常高,作為一本國(guó)際頂級(jí)雜志,一般投稿過審時(shí)間都較長(zhǎng),投稿過審時(shí)間平均 約6.0個(gè)月 約6.2周,如果想投稿該刊要做好時(shí)間安排。版面費(fèi)不祥。該雜志近兩年被列入預(yù)警名單,請(qǐng)廣大學(xué)者慎重選擇。如您想了解更多投稿政策及投稿方案,請(qǐng)咨詢客服。